Conference abstract · 3 Jul 2013
Conference abstractPublished 26 Sep 2016
Separation science that's built for biopharma
Thermo Fisher Scientific, Netherlands
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biopharmaceuticals now dominate the leading positions in both sales and revenue tables over traditional small molecule drugs and drug pipelines continue to lead by biopharmaceuticals. In addition, as some of the earlier biopharmaceuticals begin to come off patent, we are seeing tremendous growth and attention in biosimilars. Both biopharmaceuticals and biosimilars however present new challenges compared to small molecules due to their complexity and variability; and as such manufacturers need advanced analytical tools to be able to effectively characterize these biopharmaceuticals to ensure efficacy and safety of the product. In this seminar, I will overview the latest advances made by Thermo Fisher Scientific with respect to UHPLC instrumentation and column chemistries for complete biopharmaceutical separation and characterization. The Thermo Scientific™ Vanquish™ Flex UHPLC system is truly built for biopharma offering precise and reproducible separations, coupled with flexibility to execute all major biopharmaceutical applications. Our extensive portfolio of column chemistries combines with the Vanquish Flex to offer a complete solution for biopharmaceutical analysis. Examples of characterizing monoclonal antibodies to determine amino acid sequence, charge variants, aggregates, purity and glycan profiles will be presented.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 31 Jul 2020
Euro Biopharma 2018- Nanobiotechnology-based drugs for treatment of neurological disorders- Alain L. Fymat- International Institute of Medicine and Science
Conference abstract · 1 Jan 2020
Euro Biopharma 2018: Identifying Novel Anti-Osteoporosis Leads with a Chemotype-Assembly Approach- Jun Xu- School of Biotechnology and Health Sciences- Wuyi University
Conference abstract · 2012
Diabetes and built environment � Emerging cognitive science approach
Article · 31 Dec 2025
Chromatographic Separation as a Foundation for Precision Analysis in Pharmaceutical and Chemical Sciences
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Robert van Ling”
